• About
  • Subscribe
  • Contact
Monday, January 18, 2021
    Login
FutureIOT
  • Technology
    • Sensors and Instrumentation
    • Devices
    • Cloud and Platforms
    • Research and Development
    • Governance, Standards and Regulations
    • Application and Middleware
    • Security
    • Big Data and Analytics
    • AI and Machine Learning
  • Industry
    • Manufacturing
    • Transportation and Logistics
    • Retail and E-commerce
    • Banking and Financial Services
    • Government, Healthcare and Education
    • Industrial
  • Application
    • Smart Cities
    • Future Workplace
    • Commercial
    • Smart Home
    • Customer Engagement
  • Resources
  • Videos
  • Virtual Events
  • Events
No Result
View All Result
  • Technology
    • Sensors and Instrumentation
    • Devices
    • Cloud and Platforms
    • Research and Development
    • Governance, Standards and Regulations
    • Application and Middleware
    • Security
    • Big Data and Analytics
    • AI and Machine Learning
  • Industry
    • Manufacturing
    • Transportation and Logistics
    • Retail and E-commerce
    • Banking and Financial Services
    • Government, Healthcare and Education
    • Industrial
  • Application
    • Smart Cities
    • Future Workplace
    • Commercial
    • Smart Home
    • Customer Engagement
  • Resources
  • Videos
  • Virtual Events
  • Events
No Result
View All Result
FutureIOT
No Result
View All Result
Home Technology AI and Machine Learning

New Ping-An JVs to use AI to manufacture innovative drugs

Gigi Onag by Gigi Onag
August 3, 2020

Ping An Insurance Group and Shionogi (Hong Kong) have formed two joint venture (JV) companies in Shanghai and Hong Kong respectively, which  will become development centres for drugs that Shionogi is developing globally – with a focus on infectious disease and central nervous system (CNS) disorders.

Based in Osaka Japan, Shionogi & Co. is a 142-year-old global, research driven pharmaceutical company dedicated to building new platforms in the healthcare area. China-based Ping An Insurance Group, on the other hand, is a leading technology-powered financial services company that focuses on delivering both financial services and healthcare services.

The two new joint venture companies namely Ping An-Shionogi Co., Ltd is based in Shanghai and Ping An-Shionogi (Hong Kong) Limited is based in Hong Kong. Both JVs will leverage on the strengths of their parent companies combining competencies in big data and AI analytical technology with deep knowledge about diseases and strong drug-discovery capabilities. They will establish a research and development platform to efficiently create high-value-added, innovative medicines and healthcare services and deliver customised solutions for customers.

To enhance pharmaceutical manufacturing and quality control, Shionogi will fuse its manufacturing and quality control technology and knowhow with Ping An's AI technology to create a new manufacturing and quality control system. The joint ventures will use AI to monitor the manufacturing and analysis in real time, and to deploy an innovative pharmaceutical manufacturing and quality control system that offers high quality and low costs.

"We are excited to have completed the joint venture agreement and to now be prepared to make a full-scale start. Ping An Group has a world-leading platform and AI technology in the healthcare field, in addition to their strength in the insurance & financial field,” said John Keller, Ph.D., senior executive officer, senior vice president, Global Business Division, Shionogi

He added: “By fusing Ping An's strengths with Shionogi's strengths as a drug discovery-oriented pharmaceutical company in this joint venture, we will work together to provide total healthcare solutions for the benefit of patients, families, healthcare professionals and society as early as possible. We believe this alliance represents a very significant step toward our goal of creating new platforms to shape the future of healthcare."

The joint ventures will be able to supply new, generic and over-the-counter drugs to customers in China via Ping An Health Cloud, an affiliate of the Group. Ping An Good Doctor is today the largest mobile medical application in China in terms of user scale, with 315.2 million registered users, 729,000 average daily consultations, and a professional network of more than 3,000 hospitals and 94,000 pharmacies by the end of 2019. It leverages Ping An Health Cloud Company Limited's in-house full-time medical team and its proprietary AI-based medical system to cover end-to-end services including 24/7 online consultation, prescription, referral, appointment, second medical opinion and drug delivery.

Related:  SenseTime deploys AR at China’s three cultural landmarks
Tags: Artificial IntelligenceChinahealthcareHong KongPing An Insurance GroupShionogi & Cosmart manufacturing
Gigi Onag

Gigi Onag

No Result
View All Result

Recent Posts

  • IoT, AI and edge-computing projects face complex ecosystem
  • CITIC Telecom CPC expands ASEAN footprint to support smart tech
  • IDC: 10 predictions for China's smart device market in 2021
  • Thailand’s EEC on track with digital innovation hub goal
  • Baidu and Geely to produce smart EVs

Categories

  • AI and Machine Learning
  • Application
  • Application and Middleware
  • Automotive
  • Banking and Financial Services
  • Big Data and Analytics
  • Blockchain
  • Case Studies
  • Change Healthcare
  • Cloud and Platforms
  • Commercial
  • Construction
  • Consumer
  • Customer Engagement
  • Devices
  • Future Workplace
  • FutureCFO
  • Governance, Standards and Regulations
  • Government, Healthcare and Education
  • Hospitality and Tourism
  • Industrial
  • Industry
  • IT-OT integration
  • Manufacturing
  • Networking
  • Research and Development
  • Retail and E-commerce
  • Security
  • Sensors and Instrumentation
  • Smart Cities
  • smart contracts
  • Smart Home
  • Start-ups
  • Technology
  • TIBCO
  • Transportation and Logistics
  • Uncategorized
  • Videos
  • Whitepapers

About FutureIoT

Asia’s ONLY dedicated IoT publication

The race to harness the power of Internet of Things (IoT) is here. FutureIoT is dedicated to individuals, as well as public and private organizations looking to tap the potential of IoT to transform the way we live, work and do business. FutureIoT is the dedicated media that provides the single source of truth about IoT, the technology, its application and regulation, originating from Asia. << Read more >>

Quick Links

  • FutureIoT: Delivering Connected Intelligence
  • Subscribe
  • Contact
  • Privacy Policy
  • Cookie Policy
  • Terms of Use

Categories

Recent News

CITIC Telecom CPC expands ASEAN footprint to support smart tech

January 15, 2021
Image by Firmbee from Pixabay

IDC: 10 predictions for China's smart device market in 2021

January 14, 2021
  • Privacy Policy
  • Terms of Use
  • Cookie Policy

Copyright © 2019 Cxociety Pte Ltd | Designed by Pixl

No Result
View All Result
  • Technology
    • Sensors and Instrumentation
    • Devices
    • Cloud and Platforms
    • Research and Development
    • Governance, Standards and Regulations
    • Application and Middleware
    • Security
    • Big Data and Analytics
    • AI and Machine Learning
  • Industry
    • Manufacturing
    • Transportation and Logistics
    • Retail and E-commerce
    • Banking and Financial Services
    • Government, Healthcare and Education
    • Industrial
  • Application
    • Smart Cities
    • Future Workplace
    • Commercial
    • Smart Home
    • Customer Engagement
  • Resources
  • Videos
  • Virtual Events
  • Events
Login

Copyright © 2019 Cxociety Pte Ltd | Designed by Pixl

Login to your account below

or

Not a member yet? Register here

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In